Full-Time

Senior Product Manager

Customer Asset Management

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

Hybrid

Three days on-site per week required.

Category
Product (2)
,
Required Skills
Interaction Design
Market Research
Six Sigma
Product Management
Data Analysis
Requirements
  • Minimum 8 years professional experience in product management, biomedical engineering, field service, servicing capital equipment/medical devices, or equivalent role
  • Experience leading software development projects and with end-to-end software product launches
  • Experience with continuous improvement initiatives, Lean/Six Sigma, or equivalent
  • Strong track record of leading strategic initiatives from concept through to completion
  • Formal or informal leadership of cross-functional teams to implement/launch key initiatives
  • Critical thinking skills, attention to detail, and experience with data-driven decision making
  • Experience building business cases, using qualitative and quantitative data, to secure funding, resources, project/program support, and contribute to budget planning/negotiations
  • Excellent collaboration and influencing skills; proven ability to work effectively in a highly cross-functional, matrixed global environment
  • Exceptional written and verbal communication skills, with ability to develop and present impactful presentations on complex topics for cross-functional audiences (internal and external), director/VP-level leadership, and global stakeholders
  • Strong results orientation, organizational skills, and project management skills; able to prioritize and manage multiple initiatives and deadlines with attention to detail
  • Experience investigating and defining complex problems prior to solution development
  • Experience with market research, voice of customer feedback, voice of service feedback, or equivalent
  • Self-directed with awareness to proactively seek advice when needed
  • Strong knowledge of the MS Office product suite
  • Knowledge of medical device service operations or healthcare systems is a plus
  • Minimum Bachelor’s degree in a related field
  • MBA preferred
Responsibilities
  • Operate as the Sr. Product Manager for Customer Asset Management, partnering with customers, business partners, and stakeholders to drive Service innovation and ensure efficient, scalable, and customer-centric methods for monitoring, repairing, and maintaining Intuitive’s product portfolio
  • Partner with the Market Intelligence team to perform market research, test hypotheses, and support Service needs with customer experience data
  • Translate market research and customer insights into product roadmaps that align customer outcomes, the desired Service experience, and business goals
  • Partner cross-functionally with teams such as Human Factors, Interaction Design, Software Development, Global Public Affairs, and Legal to gain their input on solution analysis, product positioning, requirements, and market research strategy
  • Collaborate with Global Services leadership to ensure that asset management solutions are aligned with the Global Services operational goals and strategic vision
  • Create user requirements for software development with input from subject matter experts to ensure consideration for business risks, regulatory considerations, and strategic objectives
  • Define success metrics and work with analytics teams to monitor product performance and advocate for scalable, efficient solutions aligned with operational and financial goals
  • Collaborate with product management counterparts and key business partners to drive improvements to service procedure workflows, business systems, and diagnostic/repair tools, improving efficiency and the customer experience
  • Develop business cases to support Service solution proposals that demonstrate the desirability, viability, and feasibility for the proposed solution. Use proposals to secure support and funding from relevant stakeholders and leadership
  • Act as a connector and subject matter expert across global teams, ensuring alignment on strategy, execution, and outcomes
  • Engage in conferences, customer visits, job shadowing, and other relevant activities to build and maintain subject matter expertise and familiarity with Service, customer needs, and strategic opportunities
  • Develop and track goals for identified priorities. Ensure goals are aligned to business unit goals and corporate objectives
  • Perform other aligned duties as specified by Global Services leadership
Desired Qualifications
  • MBA preferred
  • Knowledge of medical device service operations or healthcare systems is a plus

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Simplify Jobs

Simplify's Take

What believers are saying

  • Bariatric surgery market expansion as da Vinci outperforms GLP-1 drugs for sustained weight loss.
  • Ion bronchoscopy system procedures grew 39% YoY with 1,041 installed units capturing lung cancer detection.
  • Less than 5% of eligible surgeries globally performed robotically indicates substantial international adoption runway.

What critics are saying

  • FDA Class II recalls of instruments with fraying cables disrupt 86% of Q1 recurring revenue.
  • FDA safety communication on curved tip staplers halts hospital use, eroding surgeon confidence in reliability.
  • EU MDR recertification deadline December 2028 halts 25% European sales during redesign and testing.

What makes Intuitive Surgical unique

  • 70-80% market share in soft-tissue robotics with 11,395 installed da Vinci systems globally.
  • 85% recurring revenue from instruments, accessories, and service contracts provides predictable cash flow.
  • da Vinci 5 platform expands into cardiac surgery and complex procedures previously requiring open surgery.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Intuitive Surgical who can refer or advise you

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Apr 7th, 2026
Intuitive Surgical emerges as dark horse in anti-obesity market as surgery outperforms GLP-1 drugs

Intuitive Surgical could emerge as a dark horse in the anti-obesity market as bariatric surgery proves more effective than GLP-1 drugs for long-term weight loss. A recent study of over 50,000 patients found surgery patients lost an average of 58 pounds after two years, compared to just 12 pounds for those using GLP-1 medications. The study also showed surgery delivers more sustainable results. Gastric bypass patients maintain around 52% of their excess weight loss after 10 years, whilst GLP-1 users often regain all lost weight after stopping treatment. Intuitive's da Vinci surgical system offers minimally invasive bariatric surgery options. The company generated $10.1 billion in revenue last year, up from $8.4 billion, with profit margins around 28%. Despite shares falling over 20% this year, the company's position in surgical innovation makes it a compelling long-term investment.

Yahoo Finance
Mar 29th, 2026
Intuitive Surgical shares drop 19% YTD, but analysts see 15% upside potential

Intuitive Surgical has experienced recent share price weakness, declining 3% in one day with negative returns over the past week, month and three months. The stock currently trades at $452.66, down 10.1% over one month and 19.45% year-to-date, though three-year total shareholder returns remain strong at 77.19%. The medical technology company reports annual revenue of $10.1 billion and net income of $2.9 billion, maintaining a dominant position in minimally invasive surgical technology. According to one valuation analysis, Intuitive Surgical's fair value sits at $532.46, suggesting the stock is undervalued by approximately 15% at current levels. The analysis projects 12% annual revenue growth over the next five years, supported by recurring revenues from spare parts and software licences, with profit margins expected to reach 30% from the current 28.6%.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical shares up 23% after Jim Cramer's buy recommendation

Intuitive Surgical shares rose 23% following Jim Cramer's recommendation on CNBC's Squawk on the Street in June 2025, where he urged investors to "just go buy ISRG". The medical robotics company experienced a 27% surge in October after reporting third-quarter earnings that beat analyst estimates. Revenue reached $2.51 billion against expectations of $2.40 billion, whilst adjusted earnings per share hit $2.40 versus the predicted $1.98. However, the stock declined 2.7% in January 2026 after Intuitive Surgical released preliminary fourth-quarter results, citing concerns that Medicaid funding cuts and competing products could slow growth of its robotic surgical systems. Despite the recent setback, shares remain up significantly since Cramer's initial endorsement, though they're down 7.8% over the past year.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical faces tariff headwinds and rising competition despite 19% revenue growth to $2.87B

Intuitive Surgical faces headwinds from tariffs and increased competition in the robotic-assisted surgery market, yet its fundamentals remain strong. The medical device company reported fourth-quarter revenue growth of 19% to $2.87 billion, whilst adjusted earnings per share rose 14.5% to $2.53. Procedures using its da Vinci surgical system increased 17%, with the installed base growing 12% to 11,106 units. However, the stock trades at 47.6 times forward earnings, compared to the healthcare sector average of 17.1. New competition is emerging, with Medtronic's Hugo system recently cleared and Johnson & Johnson expected to launch its own device soon. Despite these challenges, Intuitive Surgical maintains advantages through switching costs and extensive real-world data, whilst the underpenetrated robotic-assisted surgery market offers long-term growth potential.

Yahoo Finance
Mar 24th, 2026
ISRG maintains 37% operating margins in Q4 despite 95 bps tariff drag

Intuitive Surgical maintained a 37% operating margin in Q4 despite tariffs creating a 95 basis point drag, alongside higher facility costs and unfavourable product mix from newer platforms like da Vinci 5 and Ion. The company offset these pressures through product cost reductions, component savings and manufacturing efficiencies. Procedure growth of 18% in Q4 and recurring revenue now comprising 81% of total revenues provided operating leverage. Management's 2026 gross margin guidance of 67-68% suggests continued stability, even as tariff headwinds are expected to increase to roughly 1.2% of revenues. Meanwhile, Boston Scientific expanded adjusted operating margins by 100 basis points to 28% in 2025, though tariffs will offset favourable product mix in 2026. The company expects 50-75 basis points operating margin expansion in 2026 through scale efficiencies and supply-chain optimisation.